All Releases
 |
BioCryst to Present at the 7th Annual JMP Securities Healthcare Conference
Jun 28, 2012
|
11.6 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that Dr.
William P. Sheridan, Senior Vice President and Chief Medical Officer
plans to provide a corporate summary and update regarding the Company's
clinical programs at the 7th Annual JMP Securi...
|
|
BioCryst Presents Results from Its BCX4208 Gout Program at the Annual European Congress of Rheumatology
Jun 6, 2012
|
18.4 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that additional
safety and efficacy results from its BCX4208
gout program will be presented at the Annual European Congress of
Rheumatology hosted by the European League Against Rheumatism (EULAR)...
|
|
BioCryst to Present at Two Upcoming Investor Conferences
May 22, 2012
|
11.7 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives
from BioCryst are scheduled to present and provide a corporate
summary and update regarding the Company's clinical programs at the
following investor conferences:
...
|
|
BioCryst Provides Corporate Update and Reports First Quarter 2012 Financial Results
May 7, 2012
|
22.9 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial
results for the first quarter ended March 31, 2012.
"We just completed our end of Phase 2 meeting with the FDA regarding our
gout program. The agency provided clear and i...
|
|
BioCryst to Present at Two Upcoming Investor Conferences
May 1, 2012
|
11.7 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives
from BioCryst are scheduled to present and provide a corporate
summary and update regarding the Company's clinical programs at the
following investor conferences:
...
|
|
BioCryst to Report First Quarter 2012 Financial Results on May 7, 2012
Apr 25, 2012
|
12.8 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that its first
quarter 2012 financial results will be released on Monday, May 7, 2012.
BioCryst will host a conference call and webcast at 11:00 a.m. Eastern
Time to discuss the financial results ...
|
|
BioCryst to Present at Two Upcoming Investor Conferences
Feb 23, 2012
|
9.5 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that executives
from BioCryst are scheduled to present and provide a corporate summary
and update regarding the Company's clinical programs at the following
investor conferences:
...
|
|
BioCryst Reports Fourth Quarter and Full Year 2011 Financial Results
Feb 16, 2012
|
26.4 KB |
| |
Management to provide corporate update and discuss BCX5191
hepatitis C preclinical results
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial
results for the fourth quarter and full year ended December 3...
|
|
BioCryst Announces Promising Results from Preclinical Studies of BCX5191 for Hepatitis C
Feb 15, 2012
|
15.1 KB |
| |
BCX5191: Planning to file for first—in-human studies during the
fourth quarter 2012
BioCryst to discuss study outcomes during its 2011 results call
February 16 at 11:00 a.m. ET
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
...
|
|
BioCryst to Announce Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012
Feb 6, 2012
|
11.9 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that its fourth
quarter and full year 2011 financial results will be released on
Thursday, February 16, 2012. BioCryst will host a conference call and
webcast at 11:00 a.m. Eastern Time to discus...
|
|
Nancy Hutson Appointed to BioCryst's Board of Directors
Jan 19, 2012
|
10.9 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced that Nancy J.
Hutson, Ph.D. was elected to the Company's Board of Directors, effective
Friday, January 20, 2012.
"We are excited to bring Nancy onboard and welcome her to the BioC...
|
|
BioCryst Announces Positive Results from Its Ongoing BCX4208 Phase 2B Study in Patients with Gout
Jan 8, 2012
|
20.1 KB |
| |
Confirmation of favorable BCX4208 safety profile through 24 weeks
Proportion of patients reaching serum uric acid goal sustained
at 24 weeks
BioCryst to host a conference call & webcast Monday, January 9
at 10:00 a.m. ET
RESE...
|
|
BioCryst Pharmaceuticals Presents New BCX4208 Gout Data at the 2011 ACR/ARHP Annual Scientific Meeting
Nov 8, 2011
|
19.2 KB |
| |
BioCryst to host a conference call & webcast today at 7:45 p.m.
Central Time
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ:BCRX) presents new results today from
its Phase 2b randomized, double-blind, dose-response study of BCX4208
in...
|
|
BioCryst Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2011 Financial Results
Nov 2, 2011
|
24.7 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial
results for the third quarter and nine months ended September 30, 2011.
"We are pleased with the recent results of our 12-week Phase 2b gout
study, which showed that addi...
|
|
BioCryst Pharmaceuticals Announces New BCX4208 Gout Data Has Been Accepted as a Late-Breaker Oral Presentation at the ACR/ARHP 2011 Annual Scientific Meeting
Oct 24, 2011
|
15.3 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - News) today announced that results from its Phase 2b randomized, double-blind, dose-response study of BCX4208 in patients with gout who have failed to reach the clinic...
|
|
BioCryst Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 2, 2011
Oct 19, 2011
|
12.4 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that its third
quarter 2011 financial results will be released on Wednesday, November
2, 2011. BioCryst will host a conference call and webcast at 11:00 a.m.
Eastern Time to discuss the financial ...
|
|
Biocryst Pharmaceuticals Announces Changes to Its Board of Directors
Oct 11, 2011
|
10.6 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced the election of George B. Abercrombie to the Company's board of directors, effective Oc...
|
|
BioCryst Announces Positive Top-Line Results from BCX4208 Phase 2B Gout Study in Patients Not Responding to Allopurinol Alone
Oct 5, 2011
|
18.0 KB |
| |
BioCryst to host a conference call & webcast today at 8:30 AM ET
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced positive
top-line results from its Phase 2b randomized, double-blind,
dose-response study of BCX42...
|
|
BioCryst To Present New Peramivir Data at the 51st Annual ICAAC Meeting
Sep 17, 2011
|
16.2 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced the
presentation of data related to intravenous
(i.v.) peramivir for the treatment of influenza at the 51st Annual
Interscience Conference on Antimicrobial Agents & Chemotherapy (ICAAC)
...
|
|
BioCryst to Present at Three Upcoming Investor Conferences
Sep 6, 2011
|
11.7 KB |
| |
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
BioCryst
Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives
from BioCryst are scheduled to present a corporate summary and an update
regarding the Company's clinical
programs at the following investor conferences in New York:
...
|
|
|
